Public Health
Latest news
417 articles · 20 / page
Permethrin-Treated Baby Wraps: A Novel Strategy to Prevent Malaria in Young Children
A randomized controlled trial in Uganda demonstrates that permethrin-treated baby wraps significantly reduce clinical malaria incidence among infants, offering an innovative complement to bed nets for malaria prevention in sub-Saharan Afric
Is Single-Test Tuberculosis Screening Adequate Before Initiating Biologic Therapy?
A 20-year cohort study indicates that using QuantiFERON-TB Gold alone for TB screening before biologic therapy effectively reduces TB infection diagnoses and preventive treatments without increasing active TB risk, questioning the need for
Consumer Misinterpretation of Dietary Supplement Labels: Implications for Public Health and Regulation
Consumers frequently misconstrue dietary supplement labels with structure/function claims as implying disease prevention or treatment benefits, underscoring the need for clearer regulatory standards to prevent misinformation.
Unveiling the Burden and Trajectories of Perinatal Anxiety and Depression in a Major Urban Medical Center
A retrospective study identifies critical gaps in screening and treatment of perinatal anxiety and depression, revealing prevalence rates, symptom trajectories, and the impact of mental health services in 3051 women.
The Silent Threat of Chagas Disease: Understanding the ‘Kissing Bug’ Epidemic in the U.S.
Chagas disease, spread by the ‘kissing bug,’ is emerging as a hidden health threat in the U.S. Understanding its transmission, symptoms, and prevention is key to curbing this neglected tropical disease’s growing impact.
Immunogenicity and Safety of the VLA15 Lyme Borreliosis Vaccine Across Age Groups: A Phase 2 Randomised Controlled Trial and Integrative Review
This review synthesizes data on the VLA15 Lyme borreliosis vaccine candidate, demonstrating its safety and robust immunogenicity in adults, adolescents, and children, supporting multi-dose schedules and highlighting enhanced antibody respon
Enhancing Malaria Control in West Africa: Combining Non-Pyrethroid Indoor Residual Spraying or Intensive Behaviour Change Communication with Long-Lasting Insecticidal Nets
This trial shows that adding non-pyrethroid indoor residual spraying (IRS) or intensive behaviour change communication (BCC) to long-lasting insecticidal nets (LLINs) reduces malaria incidence by over 20% in West African rural communities,
Optimizing Colorectal Cancer Screening Outreach for Adults Aged 45-49: Insights From a Large-Scale Randomized Trial
A large UCLA Health randomized clinical trial found that usual care via mailed FIT outreach outperformed active choice strategies in colorectal cancer screening uptake among adults aged 45 to 49 years, highlighting the challenges in engagin
Ecolabels and the Impact on Healthfulness and Carbon Footprint of Restaurant Meal Choices: A Randomized Clinical Trial
This clinical trial found that ecolabels on restaurant menus can reduce the carbon footprint of meals without compromising nutritional quality, highlighting ecolabels as a promising low-cost strategy for sustainable dining.
Does Using Your Phone While Charging Increase Radiation? Unpacking the Science and Safety
Explore how phone charging affects electromagnetic radiation levels, what this means for health, and practical tips to reduce exposure while keeping your device safe.
Unveiling the Hidden Risks of 5G Radiation: Impacts on Male Fertility
Recent animal studies suggest daily 5G phone radiation exposure may significantly impair sperm quality, raising concerns over modern lifestyle and reproductive health.
Technology, Ethics, and Equity: Navigating the Three Core Challenges in Large-Scale Genomic Newborn Screening for Universal Health Benefits
Genomic newborn screening shows promise for early detection of a wider range of diseases but raises significant technological, ethical, and equity challenges before becoming a universally accessible public health tool.
Hospital Addiction Consult Services: A Promising Step to Reduce Emergency Visits Among Patients with Opioid Use Disorder
A hospital-based addiction consult program lowered emergency department visits in opioid use disorder patients but did not reduce hospitalizations or mortality, highlighting the need for comprehensive care beyond hospital walls.
Impact of Physician-Personalized Videos and Infographics on Influenza Vaccination Rates: Findings from a Randomized Clinical Trial
This trial assessed if videos and infographics from primary care physicians improve flu vaccination rates; overall effects were minimal, but notable improvements occurred in children.
Impact of Graphic Health Warnings on Little Cigar and Cigarillo Use: Evidence from a Randomized Clinical Trial
A randomized trial demonstrates that graphic health warnings on little cigars and cigarillos significantly increase quitting intentions and related behaviors compared to FDA text-only warnings or no warnings, highlighting the need for enhan
Impact of a $40 Monthly Healthy Food Benefit on Food Security and Fruit and Vegetable Intake in Lower-Income Populations
A cohort study found that a $40 monthly healthy food benefit program significantly improved food security and increased the frequency of fruit and vegetable consumption among lower-income urban adults, highlighting its potential to reduce n
Optimizing Hepatitis C Screening in Emergency Departments: Insights from the DETECT Hep C Randomized Clinical Trial
The DETECT Hep C trial demonstrates nontargeted HCV screening in emergency departments identifies more new infections than risk-based approaches, though linkage to care remains suboptimal, underscoring the need for innovative treatment mode
The Dawn of the “No-Clinical-Trial” Era for Biosimilars: FDA’s Historic Ustekinumab Approval Shift
The US FDA’s unprecedented exemption of clinical efficacy studies for a ustekinumab biosimilar marks a transformative regulatory milestone, reshaping biosimilar development, market dynamics, and patient access worldwide.
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults: Insights from the DANFLU-2 Randomized Clinical Trial
The DANFLU-2 trial demonstrates that high-dose influenza vaccine reduces cardiovascular and cardiorespiratory hospitalizations compared to standard-dose in adults ≥65 years, with similar benefits across subgroups including heart failure and
Browse by specialty
Open language-specific specialty feeds and department pages.